Frequency of adverse reactions to influenza vaccine in the elderly. A randomized, placebo-controlled trial.
Concern about side effects constitutes a major deterrent to patient compliance with influenza vaccination, yet there is a paucity of data about the occurrence of adverse reactions in the population targeted for immunization. We conducted a randomized, double-blind, crossover trial to compare the frequency of adverse reactions following administration of 1988-1989 trivalent split-antigen influenza vaccine and saline placebo. Outpatient veterans 65 years of age or over (n = 336) were recruited by mail and were randomly assigned to receive vaccine followed 2 weeks later by placebo injection or placebo followed 2 weeks later by vaccine. There was no significant difference between influenza vaccine and placebo with respect ot the proportion of subjects reporting disability or systemic symptoms.
Hennepin County Medical Center, Minneapolis, MN 55415.
K L
KL
Margolis
K L
KL
Nichol
G A
GA
Poland
R E
RE
Pluhar
D000368:Aged; D004311:Double-Blind Method; D006801:Humans; D007252:Influenza Vaccines / Q000009:adverse effects*; D007251:Influenza, Human / Q000517:prevention & control*; D008910:Minnesota; D010865:Pilot Projects; D011897:Random Allocation; D016032:Randomized Controlled Trials as Topic
D007252:Influenza Vaccines